Delivery of epilepsy care to adults with intellectual and developmental disabilities

Neurology

Volumn 85, Issue 17, 2015, Pages 1512-1521

  Devinsky, Orrin ^a   Asato, Miya ^a   Camfield, Peter ^b   Geller, Eric ^c   Kanner, Andres M ^d   Keller, Seth ^e   Kerr, Michael ^f   Kossoff, Eric H ^g   Lau, Heather ^a   Kothare, Sanjeev ^a   Singh, Baldev K ^h   Wirrell, Elaine ^a  

^a MAYO CLINIC   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c SAINT BARNABAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e Advocare Neurology of South Jersey   (United States)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ACCIDENTAL INJURY; ADULT; ADULTHOOD; BURN; CAREGIVER SUPPORT; COMORBIDITY; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DIET THERAPY; EMERGENCY WARD; EPILEPSY; EXOME; GENE SEQUENCE; GENETIC COUNSELING; HAPLOINSUFFICIENCY; HEAD INJURY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HOSPITAL PATIENT; HUMAN; INTELLECTUAL IMPAIRMENT; METABOLIC DISORDER; MICROARRAY ANALYSIS; MORBIDITY; MORTALITY; NERVE STIMULATION; ONSET AGE; OUTPATIENT; POLYPHARMACY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; VAGUS NERVE; VAGUS NERVE STIMULATION; COMPLICATION; DRUG RESISTANT EPILEPSY; NEUROSURGERY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; TRANSITION TO ADULT CARE;

ADULT; ANTICONVULSANTS; CONTINUITY OF PATIENT CARE; DEVELOPMENTAL DISABILITIES; DRUG RESISTANT EPILEPSY; EPILEPSY; HUMANS; INTELLECTUAL DISABILITY; NEUROSURGICAL PROCEDURES; TRANSITION TO ADULT CARE; VAGUS NERVE STIMULATION;

EID: 84945309670     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002060     Document Type: Review

References (51)

1. Matthews T, Weston N, Baxter H, et al. A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and carer stress. J Intellect Disabil Res 2008;52:163-173.
2. Sangani M, Shahid A, Amina S, et al. Improvement of myoclonic epilepsy in Down syndrome treated with leve-tiracetam. Epileptic Disord 2010;12:151-154.
3. Lefter S, Costello DJ, McNamara B, et al. Clinical and EEG features of seizures in adults with down syndrome. J Clin Neurophysiol 2011;28:469-473.
4. Camfield C, Camfield P. Preventable and unpreventable causes of childhood-onset epilepsy plus mental retardation. Pediatrics 2007;120:e52-e55.
5. Camfield C, Camfield P, Gordon K, et al. Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication. J Pediatr 1993;122:861-868.
6. Kerr M, Kluger G, Philip S. Evolution and management of Lennox-Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue? Epileptic Disord 2011;13(suppl 1):S15-S26.
7. Moeschler JB, Shevell M; Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics 2014;134: e903-e918.
8. Battaglia A, Doccini V, Bernardini L, et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol 2013;17:589-599.
9. Mullen SA, Carvill GL, Bellows S, et al. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology 2013;81:1507-1514.
10. van Karnebeek CD, Shevell M, Zschocke J, et al. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. Mol Genet Metab 2014;111:428-438.
11. Beavis J, Kerr M, Marson AG. Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev 2007;CD005399.
12. Kerr MP, Baker GA, Brodie MJ. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Epilepsy Behav 2005;7:472-480.
13. Ettinger AB, Weisbrot DM, Saracco J, et al. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998;39:874-877.
14. Beran RG, Gibson RJ. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotri-gine. Epilepsia 1998;39:280-282.
15. Wolf SM, Shinnar S, Kang H, et al. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1995;36:1203-1205.
16. Devinsky O. What do you do when they grow up? Approaches to seizures in developmentally delayed adults. Epilepsia 2002;43(suppl 3):71-79.
17. Rutecki PA, Gidal BE. Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs. Epilepsy Behav 2002;3: 24-31.
18. Kossoff EH, Cervenka MC, Henry BJ, et al. A decade of the modified Atkins diet (2003-2013): results, insights, and future directions. Epilepsy Behav 2013;29: 437-442.
19. Levy ML, Levy KM, Hoff D, et al. Vagus nerve stimula tion therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimula tion therapy patient outcome registry. J Neurosurg Pediatr 2010;5:595-602.
20. Heck CN, King-Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable par tial onset epilepsy treated with responsive neurostimula-tion: final results of the RNS system pivotal trial. Epilepsia 2014;55:432-441.
21. Liu E, Duchowny M. Developmental disabilities and epilepsy surgery. In: Devinsky O, Westbrook L, eds. Epilepsy and Developmental Disabilities. Boston: Butterworth-Heinemann; 2002.
22. Carlson C, Teutonico F, Elliot RE, et al. Bilateral invasive electroencephalography in patients with tuberous sclerosis complex: a path to surgery? J Neurosurg Pediatr 2011; 7: 421-430.
23. Heslop P, Blair PS, Fleming P, et al. The confidential inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study. Lancet 2014;383:889-895.
24. Brylewski J, Wiggs L. Sleep problems and daytime chal lenging behaviour in a community-based sample of adults with intellectual disability. J Intellect Disabil Res 1999;43: 504-512.
25. Kotagal S, Gibbons VP, Stith JA. Sleep abnormalities in patients with severe cerebral palsy. Dev Med Child Neurol 1994;36:304-311.
26. Turky A, Felce D, Jones G, et al. A prospective case control study of psychiatric disorders in adults with epi lepsy and intellectual disability. Epilepsia 2011;52: 1223-1230.
27. Ogg-Groenendaal M, Hermans H, Cleaessens B. A systematic review on the effect of exercise interven tions on challenging behavior for people with intellectual disabilities. Res Dev Disabil 2014;35: 1507-1517.
28. Gross A, Devinsky O, Westbrook LE, et al. Psychotropic medication use in patients with epilepsy: effect on seizure frequency. J Neuropsychiatry Clin Neurosci 2000;12: 458-464.
29. Hanzel TE, Bauernfeind JD, Kalachnik JE, et al. Results of barbiturate antiepileptic drug discontinuation on anti-psychotic medication dose in individuals with intellectual disability. J Intellect Disabil Res 2000;44:155-163.
30. Conry JA, Ng YT, Paolicchi JM, et al. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia 2009; 50:1158-1166.
31. Vossler DG, Morris GL, Harden CL, et al. Tiagabine in clinical practice: effects on seizure control and behavior. Epilepsy Behav 2013;28:211-216.
32. Beavis J, Meek A, Felce D, et al. A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities. Seizure 2009;18:279-284.
33. Espie CA, Watkins J, Curtice L, et al. Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neuro-surg Psychiatry 2003;74:1485-1492.
34. Antonacci DJ, Manuel C, Davis E. Diagnosis and treatment of aggression in individuals with developmental disabilities. Psychiatr Q 2008;79:225-247.
35. Doehring P, Reichow B, Palka T, et al. Behavioral approaches to managing severe problem behaviors in children with autism spectrum and related developmental disorders: a descriptive analysis. Child Adolesc Psychiatr Clin N Am 2014;23:25-40.
36. Buono S, Scannella F, Palmigiano MB, et al. Self-injury in people with intellectual disability and epilepsy: a matched controlled study. Seizure 2012;21:160-164.
37. Morgan CL, Baxter H, Kerr MP. Prevalence of epilepsy and associated health service utilization and mortality among patients with intellectual disability. Am J Ment Retard 2003;108:293-300.
38. Beghi E, Cornaggia C; REST-1 Group. Morbidity and accidents in patients with epilepsy: results of a European cohort study. Epilepsia 2002;43:1076-1083.
39. Nakken KO, Lossius R. Seizure-related injuries in multi-handicapped patients with therapy-resistant epilepsy. Epi-lepsia 1993;34:836-840.
40. Willgross TG, Yohannes AM, Mitchell D. Review of risk factors and preventative strategies for fall-related injuries in people with intellectual disabilities. J Clin Nurs 2010;19: 2100-2109.
41. Wirrell EC. Epilepsy-related injuries. Epilepsia 2006;47 (suppl 1):79-86.
42. Buck D, Baker GA, Jacoby A, et al. Patients' experiences of injury as a result of epilepsy. Epilepsia 1997;38:439-444.
43. Sakauchi M, Oguni H, Kato I, et al. Mortality in Dravet syndrome: search for risk factors in Japanese patients. Epi-lepsia 2011;52(suppl 2):50-54.
44. Hauser WA, Hesdorffer DC; E. Foundation. Epilepsy: Frequency, Causes and Consequences. New York: Epilepsy Foundation of America; 1990.
45. Sillanpaa M, Shinnar S. Long-term mortality in childhood-onset epilepsy. N Engl J Med 2010;363:2522-2529.
46. Walczak TS, Leppik IE, D'Amelio M, et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001;56:519-525.
47. Young C, Shankar R, Palmer J, et al. Does intellectual disability increase sudden unexpected death in epilepsy (SUDEP) risk? Seizure 2015;25:112-116.
48. Devinsky O. Sudden, unexpected death in epilepsy. N Engl J Med 2011;365:1801-1811.
49. Hsieh K, Heller T, Miller AB. Risk factors for injuries and falls among adults with developmental disabilities. J Intellect Disabil Res 2001;45:76-82.
50. Hochstenbach R, Buizer-Voskamp JE, Vorstman JA, et al. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. Cytogenet Genome Res 2011;135:174-202.
51. Pescosolido MF, Gamsiz ED, Nagpal S, et al. Distribution of disease-associated copy number variants across distinct disorders of cognitive development. J Am Acad Child Ado-lesc Psychiatry 2013;52:414-430.